NICM
CVS icon

Neo Ivy Capital Management’s CVS Health CVS Stock Holding History

Neo Ivy Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$811K Buy
+11,290
New +$870K 0.21% 158
2025
Q4 		– Sell
-10,626
Closed -$801K – 383
2025
Q3 		$801K Buy
10,626
+9,372
+747% +$642K 0.2% 170
2025
Q2 		$86.5K Buy
+1,254
New +$82.2K 0.03% 302
2024
Q3 		– Sell
-13,596
Closed -$803K – 297
2024
Q2 		$803K Buy
+13,596
New +$850K 0.16% 156
2023
Q4 		– Sell
-4,160
Closed -$290K – 329
2023
Q3 		$290K Sell
4,160
-45,601
-92% -$3.23M 0.13% 205
2023
Q2 		$3.44M Buy
+49,761
New +$3.54M 1.81% 4
2022
Q4 		– Sell
-1,248
Closed -$119K – 384
2022
Q3 		$119K Sell
1,248
-2,640
-68% -$261K 0.31% 123
2022
Q2 		$360K Sell
3,888
-1,620
-29% -$158K 0.96% 2
2022
Q1 		$558K Buy
+5,508
New +$579K 0.5% 48
2021
Q4 		– Sell
-2,554
Closed -$166K – 470
2021
Q3 		$166K Sell
2,554
-672
-21% -$56.3K 0.19% 175
2021
Q2 		$269K Buy
3,226
+2,900
+890% +$237K 0.27% 138
2021
Q1 		$25K Sell
326
-12,561
-97% -$915K 0.03% 385
2020
Q4 		$880K Sell
12,887
-2,195
-15% -$143K 0.98% 4
2020
Q3 		$880K Buy
15,082
+12,528
+491% +$780K 0.89% 4
2020
Q2 		$166K Buy
2,554
+2,207
+636% +$139K 0.19% 175
2020
Q1 		$21K Sell
347
-9,097
-96% -$607K 0.03% 374
2019
Q4 		$702K Buy
9,444
+9,354
+10,393% +$657K 0.81% 9
2019
Q3 		$5K Buy
+90
New +$5.33K ﹤0.01% 264
2019
Q1 		– Sell
-17,192
Closed -$1.13M – 306
2018
Q4 		$1.13M Buy
+17,192
New +$1.28M 0.89% 11

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neo Ivy Capital Management's CVS Position: Q1 2026 in Review

Neo Ivy Capital Management opened a new position in CVS Health (CVS) in Q1 2026: 11,290 shares worth $811K. The stake represents 0.21% of the portfolio and ranks #158 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in CVS as recently as Q3 2025.

Neo Ivy Capital Management first reported a position in CVS in Q4 2018 and has held it in 19 quarters since. The position peaked at $3.44M in Q2 2023. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Neo Ivy Capital Management held 11,290 shares of CVS Health worth $811K as of Q1 2026.
  • CVS Health was a new Neo Ivy Capital Management position in Q1 2026.
  • CVS Health made up 0.21% of Neo Ivy Capital Management's portfolio in Q1 2026, its #158 holding.
  • Neo Ivy Capital Management first reported a position in CVS Health in Q4 2018 and has held it in 19 quarters since.
  • Neo Ivy Capital Management's CVS Health position peaked at $3.44M in Q2 2023.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.